Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCNS Pharmaceuticals, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

CNS Pharmaceuticals, Inc.

$5.24Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
    • Revenue & profit
    • Revenue by segment
    • Launches
    • Revenue concentration
    • Margins
    • Contracted revenue
    • Off-balance-sheet commitments
    • Cash flow
    • Cash & debt
    • Earnings per share
    • P/E ratio
    • Share count & dilution
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financial graphs

Metrics

Revenue & profit
Revenue by segment
Margins
Contracted revenue
Cash flow
Cash & debt
Earnings per share
Share count & dilution

Metrics

Compare cash generated by the business, spending on long-lived assets, and what remains afterward.Formula: Free cash flow = operating cash flow − capital expenditures
$
202520182019202020212022202320242025-15M-10M-5M0
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    Latest period 2025. Operating cash flow -13.8M. Capex -18.2K. Free cash flow -13.8M.
    Operating cash flowCapexFree cash flow
    Compare the company’s cash cushion with its borrowings. Negative net cash means debt is greater than cash.Formula: Net cash = cash − debt
    20262018201920202021202220232024202505M10M15M20M
        Latest period 2026. Cash 20M. Debt 0.
        CashDebtNet cash
        Profit for each share over the trailing 12 months, adjusted for stock splits.Formula: Earnings available to common shareholders ÷ weighted-average shares
        $/shareUsing split history cached 2026-09-23; assuming no new splits
        202520182019202020212022202320242025-200,000,000.00-150,000,000.00-100,000,000.00-50,000,000.000.00
          • Earnings period 2018-01-01 to 2018-12-31. Shares as of 2018-12-31: 12,694,504 source shares.
          • Earnings period 2019-01-01 to 2019-12-31. Shares as of 2019-12-31: 16,450,234 source shares.
          • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2020-12-31: 23,856,151 source shares.
          • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2021-12-31: 949,052 source shares.
          • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 1,617,325 source shares.
          • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 2,486 source shares.
          • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 117,796 source shares.
          • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 632,516 source shares.
          Latest period FY 2025. EPS (TTM) -25.06.
          EPS (TTM)
          How much investors pay for each dollar of the company’s yearly earnings. It is not useful when the company has no profit.Formula: Share price ÷ trailing 12-month EPS
          Using split history cached 2026-09-23; assuming no new splits
          historical price missing or staleMissing202520182019202020212022202320242025-15x-10x-5x0x
          • FY 2018: historical price missing or stale
          • Earnings period 2018-01-01 to 2018-12-31. Shares as of 2018-12-31: 12,694,504 source shares.
          • Earnings period 2019-01-01 to 2019-12-31. Shares as of 2019-12-31: 16,450,234 source shares. Nearby weekly price on 2020-01-03.
          • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2020-12-31: 23,856,151 source shares. Weekly price on 2020-12-31.
          • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2021-12-31: 949,052 source shares. Weekly price on 2021-12-31.
          • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 1,617,325 source shares. Nearby weekly price on 2022-12-30.
          • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 2,486 source shares. Nearby weekly price on 2023-12-29.
          • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 117,796 source shares. Nearby weekly price on 2025-01-03.
          • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 632,516 source shares. Nearby weekly price on 2026-01-02.
          Latest period FY 2025. P/E ratio -0.2x.
          P/E ratio
          See how the number of shares changes over time. More shares can mean each existing share owns a smaller slice of the company.Formula: Outstanding shares = issued shares − treasury shares Share-count growth = (current shares ÷ previous shares − 1) × 100%
          Stock split history may be out of date.
          202620182019202020212022202320242025010M20M30M40M
          2022-11-29: Reverse stock split 1-for-30
          2024-06-05: Reverse stock split 1-for-50
          2025-02-21: Reverse stock split 1-for-50
          2025-07-22: Reverse stock split 1-for-12
              Latest period 2026. Shares outstanding 1.5M. Class detail unavailable 1.5M.
              Class detail unavailableStock split